Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ 24878787!ä!24878787 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Rev+Bras+Reumatol 2014 ; 54 (1): 21-6 Nephropedia Template TP {{tp|p=24878787|t=2014. Frequency of antiparvovirus B19 antibodies in rheumatoid arthritis and systemic lupus erythematosus |pdf=|usr=}}{{24878787}} gab.com Text Frequency of antiparvovirus B19 antibodies in rheumatoid arthritis and systemic lupus erythematosus JO: Rev Bras Reumatol http://www.kidney.de/pget.php?&tw=1&pmid=24878787 #FOAvip OBJECTIVE: To determine the frequency of antiparvovirus B19 (B19) antibodies in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), and the possible correlation of anti-B19 seropositivity with disease activity and quality of life. PATIENTS AND METHODS: Serum samples from 57 patients with RA, 45 with SLE and 65 healthy controls were used. We applied protocol with clinical data, and the Disease Activity Score 28 (DAS 28), Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) and Health Assessment Questionnaire (HAQ) indexes. The anti-B19 serology was done by enzyme-linked immunosorbent assay (ELISA). RESULTS: The mean age of patients was 42.74 +/- 14.09 years, and of controls was 38.38 +/- 13.42 years. 79 patients had active disease (77.5%), and 23 had inactive disease (22.5%). Anti-B19 (IgG) was positive in 49 (86.0%; CI 95% 77.0-95.0) RA patients, 38 (84.4%; CI 95% 73.9-95.0) SLE patients, and 40 (61.5%; CI 95% 49.7-73.4) controls (p = 0.002). Anti-B19 (IgM) was positive in 3 (5.3%; CI 95% 0.0-11.1) RA patients, in 7 (15.6%; CI 95% 5.0-26,2) SLE patients, and in 1 (1.5%; CI 95% 0.0-4.5) control (p = 0.011).There was no correlation of anti-B19 reactivity with disease activity and with DAS 28, HAQ and SLEDAI indexes. CONCLUSION: This study demonstrated that the studied population is exposed to infection by B19, which demands attention with its manifestations, especially among patients at greatest risk, such as those immunosuppressed. Twit Text FOAVip Frequency of antiparvovirus B19 antibodies in rheumatoid arthritis and systemic lupus erythematosus ????Rev Bras Reumatol http://www.kidney.de/pget.php?&tw=1&pmid=24878787 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24878787 #FOAvip English Wikipedia <ref>{{Cite pmid|24878787}}</ref> Frequency of antiparvovirus B19 antibodies in rheumatoid arthritis and systemic lupus erythematosus #MMPMID24878787 da Silva CP; Rego J; Barbosa Vde S; Cruz VA; da Silva NA Rev Bras Reumatol 2014[Jan]; 54 (1): 21-6 PMID24878787show ga OBJECTIVE: To determine the frequency of antiparvovirus B19 (B19) antibodies in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), and the possible correlation of anti-B19 seropositivity with disease activity and quality of life. PATIENTS AND METHODS: Serum samples from 57 patients with RA, 45 with SLE and 65 healthy controls were used. We applied protocol with clinical data, and the Disease Activity Score 28 (DAS 28), Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) and Health Assessment Questionnaire (HAQ) indexes. The anti-B19 serology was done by enzyme-linked immunosorbent assay (ELISA). RESULTS: The mean age of patients was 42.74 +/- 14.09 years, and of controls was 38.38 +/- 13.42 years. 79 patients had active disease (77.5%), and 23 had inactive disease (22.5%). Anti-B19 (IgG) was positive in 49 (86.0%; CI 95% 77.0-95.0) RA patients, 38 (84.4%; CI 95% 73.9-95.0) SLE patients, and 40 (61.5%; CI 95% 49.7-73.4) controls (p = 0.002). Anti-B19 (IgM) was positive in 3 (5.3%; CI 95% 0.0-11.1) RA patients, in 7 (15.6%; CI 95% 5.0-26,2) SLE patients, and in 1 (1.5%; CI 95% 0.0-4.5) control (p = 0.011).There was no correlation of anti-B19 reactivity with disease activity and with DAS 28, HAQ and SLEDAI indexes. CONCLUSION: This study demonstrated that the studied population is exposed to infection by B19, which demands attention with its manifestations, especially among patients at greatest risk, such as those immunosuppressed. |Adolescent[MESH] |Adult[MESH] |Aged[MESH] |Antibodies, Viral/*blood[MESH] |Arthritis, Rheumatoid/*blood[MESH] |Humans[MESH] |Immunoglobulin G/*blood[MESH] |Immunoglobulin M/*blood[MESH] |Lupus Erythematosus, Systemic/*blood[MESH] |Middle Aged[MESH] |Parvovirus B19, Human/*immunology[MESH]Frequency of antiparvovirus B19 antibodies in rheumatoid arthritis and(epmc).pdf DeepDyve Pubget Overpricing